Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)

NCT06150898 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Early-stage Breast Cancer
Estrogen-receptor-positive Breast Cancer

Interventions

PROCEDURE: Prospective data and sample collection
DRUG: Ketorolac 10 Mg Oral Tablet
DRUG: Pregabalin 75mg
DRUG: Omeprazole 20mg Capsule

Sponsor

Jules Bordet Institute

Collaborators

[object Object]